Science News December 3, 2021
Laura Sanders

Drugs that offer profound shifts in consciousness still face many hurdles

Kanu Caplash was lying on a futon in a medical center in Connecticut, wearing an eye mask and listening to music. But his mind was far away, tunneling down through layer upon layer of his experiences. As part of a study of MDMA, a psychedelic drug also known as molly or ecstasy, Caplash was on an inner journey to try to ease his symptoms of post-traumatic stress disorder.

On this particular trip, Caplash, now 22, returned to the locked bathroom door of his childhood home. As a kid, he used to lock himself in to escape the yelling adults outside. But now, he was both outside the locked door,...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: Mental Health, Provider
URAC CEO talks virtual care access, tele-mental health, post-COVID regs
Health Plans, Insurance Issuers Are Failing to Deliver Full Access for Mental Health and Substance-use Disorder Benefits
Getting Mental Health Back On The World’s Agenda
Opinion: How Black hair racism affects mental health care
Employers Identify Workforce Mental Health Priorities for 2022